MedPath

Pharmaceutical Companies

JAMJOOM PHARMACEUTICALS COMPANY FACTORY

๐Ÿ‡ธ๐Ÿ‡ฆSaudi Arabia
Ownership
-
Established
-
Employees
-
Market Cap
$3.2B
Website
-

Olink Holding AB

๐Ÿ‡ธ๐Ÿ‡ชSweden
Ownership
-
Established
-
Employees
707
Market Cap
$3.2B
Website
-
Olink Holding AB has a proprietary and patented Proximity Extension Assay technology, which enables researchers to use one platform for discovery to clinical trials to diagnostic applications utilizing the established infrastructure of...
VIRBAC SA logo

VIRBAC SA

๐Ÿ‡ต๐Ÿ‡นPortugal
Ownership
Public
Established
1968-01-01
Employees
5.4K
Market Cap
$3.1B
Website
http://www.virbac.fr
KYMERA THERAPEUTICS INC logo

KYMERA THERAPEUTICS INC

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
Public
Established
2017-01-01
Employees
187
Market Cap
$3.1B
Website
http://www.kymeratx.com

BAVARIAN NORDIC

๐Ÿ‡ฉ๐Ÿ‡ฐDenmark
Ownership
-
Established
1992-01-01
Employees
759
Market Cap
$3.1B
Website
http://www.bavarian-nordic.com

XENON PHARMACEUTICALS

๐Ÿ‡ฎ๐Ÿ‡ณIndia
Ownership
-
Established
1996-01-01
Employees
-
Market Cap
$3.1B
Website
http://www.xenon-pharma.com/
SpringWorks Therapeutics logo

SpringWorks Therapeutics

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
Public
Established
2017-01-01
Employees
305
Market Cap
$3B
Website
http://www.springworkstx.com
Springworks Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the application of a medicine approach to acquiring, developing, and commercializing medicines. Its pipeline includes Nirogacestat,...
Arrowhead Pharmaceuticals logo

Arrowhead Pharmaceuticals

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
Public
Established
1989-01-01
Employees
525
Market Cap
$2.9B
Website
http://www.arrowheadpharma.com
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include...

Hutchmed Limited

๐Ÿ‡จ๐Ÿ‡ณChina
Ownership
-
Established
-
Employees
-
Market Cap
$2.9B
Website
-

MoonLake Immunotherapeutics

๐Ÿ‡จ๐Ÿ‡ญSwitzerland
Ownership
Public
Established
-
Employees
50
Market Cap
$2.9B
Website
http://www.moonlaketx.com
Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian...
ยฉ Copyright 2025. All Rights Reserved by MedPath